[{"data":1,"prerenderedAt":220},["ShallowReactive",2],{"story-72873-en":3},{"id":4,"slug":5,"slugs":5,"currentSlug":5,"title":6,"subtitle":7,"coverImagesSmall":8,"coverImages":9,"content":48,"questions":49,"relatedArticles":74,"body_color":218,"card_color":219},"72873",null,"Medicare Drug Price Negotiations 2028 | Health Product Seller Opportunities","- $27B in negotiated drug spending creates $200B decade-long savings, driving 15+ medication price reductions and reshaping health product demand for e-commerce sellers",[],[10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47],"https://www.ukiahdailyjournal.com/wp-content/uploads/2026/01/Trump_23810.jpg?w=525","https://dims.apnews.com/dims4/default/1ad9da1/2147483647/strip/true/crop/6000x3994+0+3/resize/320x213!/quality/90/?url=https%3A%2F%2Fassets.apnews.com%2F63%2F30%2Fcb0730e30dbd1312b42b034b8c2d%2F8e294636b45b47e5a4b8c12fdf14d9a6","https://www.timescall.com/wp-content/uploads/2026/01/Trump_23810.jpg?w=525","https://www.reporterherald.com/wp-content/uploads/2026/01/Trump_23810.jpg?w=525","https://www.journal-advocate.com/wp-content/uploads/2026/01/Trump_23810.jpg?w=525","https://s.yimg.com/os/en/the_hill_articles_341/d8382cd97391eebc263e4ba4899a4e41","https://ts2.tech/wp-content/uploads/2026/01/eli-lilly-stock-price-falls-over-2-as-medicare-puts-trulicity-on-2028-price-talk-list-featured.jpg","https://www.statnews.com/wp-content/uploads/2024/04/GettyImages-1031028924-645x645.jpg","https://res.cloudinary.com/graham-media-group/image/upload/f_auto/q_auto/c_thumb,w_700/v1/media/gmg/QYLVN6GNGRGG3KTYX2FEDZEEIM.jpg?_a=DATAg1eAZAA0","https://www.macombdaily.com/wp-content/uploads/2026/01/Trump_23810.jpg?w=525","https://blog.tipranks.com/wp-content/uploads/2026/01/shutterstock_1514053007-750x406.jpg","https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iX8hzS7EO9Ck/v0/-1x-1.webp","https://www.dailynews.com/wp-content/uploads/2026/01/Trump_23810.jpg?w=525","https://thehill.com/wp-content/uploads/sites/2/2025/11/AP25017529990217-e1763419585220.jpg?strip=1","https://www.broomfieldenterprise.com/wp-content/uploads/2026/01/Trump_23810.jpg?w=525","https://www.readingeagle.com/wp-content/uploads/2026/01/Trump_23810.jpg?w=525","https://www.livemint.com/lm-img/img/2026/01/28/1600x900/logo/US-POLITICS-JUSTICE-FRAUD-4_1769571363001_1769571373663.jpg","https://www.orovillemr.com/wp-content/uploads/2026/01/Trump_23810.jpg?w=525","https://www.willitsnews.com/wp-content/uploads/2026/01/Trump_23810.jpg?w=525","https://zeta.creativecirclecdn.com/livingston/original/20260127-231308-957-wirestory_d4753de72caf3acd3d7a5f4e7c2fe7c6_16x9_1600.jpg","https://www.reuters.com/resizer/v2/K2B6CT444VIJXFTEGBEDBVGP5Q.jpg?auth=b0a6e5a0a1e77c30387511ef8a0932ba5a01021a6c6d8388a9a407c5617782d2&height=1005&width=1920&quality=80&smart=true","https://www.santacruzsentinel.com/wp-content/uploads/2026/01/Trump_23810.jpg?w=525","https://media-cldnry.s-nbcnews.com/image/upload/t_nbcnews-fp-1024-512,f_auto,q_auto:best/rockcms/2024-04/240410-botox-ch-1536-413096.jpg","https://www.baltimoresun.com/wp-content/uploads/2026/01/Trump_23810.jpg?w=525","https://www.mendocinobeacon.com/wp-content/uploads/2026/01/Trump_23810.jpg?w=525","https://www.republicanherald.com/wp-content/uploads/2026/01/Trump_23810.jpg?w=525","https://s.hdnux.com/photos/01/62/41/24/30020872/3/ratio3x2_1920.jpg","https://etimg.etb2bimg.com/photo/127669268.cms","https://bloximages.newyork1.vip.townnews.com/tdtnews.com/content/tncms/assets/v3/editorial/b/28/b289210e-f55c-5d98-a37d-9c2620c6ae71/6979538256ddc.image.jpg?resize=400%2C267","https://res.cloudinary.com/graham-media-group/image/upload/f_auto/q_auto/d_https:::media.clickondetroit.com:theme:images:placeholder-16x9-wdiv.png/c_scale,w_640/v1/media/gmg/QYLVN6GNGRGG3KTYX2FEDZEEIM.jpg?_a=DAJHqpE+ZAAA","https://image.cnbcfm.com/api/v1/image/108230181-17637564612025-11-21t201935z_1759060884_rc2z0ia94ua1_rtrmadp_0_lilly-stocks.jpeg?v=1765919533&w=1600&h=900","https://www.lowellsun.com/wp-content/uploads/2026/01/Trump_23810.jpg?w=525","https://bloximages.newyork1.vip.townnews.com/thederrick.com/content/tncms/assets/v3/editorial/2/54/2548a4a8-2b6d-5506-b994-a22d0988ba1d/69795380a2734.image.jpg?resize=1200%2C800","https://www.dailycamera.com/wp-content/uploads/2026/01/Trump_23810.jpg?w=525","https://bloximages.chicago2.vip.townnews.com/oskaloosa.com/content/tncms/assets/v3/editorial/8/1a/81a88c1f-62ce-53f7-b943-8a6d0ef70cbd/697954c7b3f91.image.jpg?resize=400%2C267","https://insights.citeline.com/resizer/v2/C3PRKX2Y6FEBDIVQ3SKPMRE54U.jpg?smart=true&auth=cfb8c8bf39b116011922d592d0eb912a5839d8be6ac9ac8b6c9a83dcdc984e24&width=700&height=394","https://ts2.tech/wp-content/uploads/2026/01/pfizer-stock-rises-after-medicare-flags-xeljanz-for-2028-price-talks-what-investors-watch-next-featured.jpg","https://thehill.com/wp-content/uploads/sites/2/2024/04/AP65960697825-e1712858235409.jpg?strip=1","The **Medicare Drug Price Negotiation Program** entered its third expansion cycle on January 27, 2025-2026, with **15 high-cost medications** selected for price negotiations, including blockbuster drugs like **Botox** (AbbVie), **Trulicity** (Eli Lilly), and **Biktarvy** (Gilead Sciences). These drugs collectively represent **$27 billion in annual Medicare spending**, with negotiated prices taking effect January 1, 2028. This represents the first cycle to include **Medicare Part B drugs** (administered in clinical settings), expanding government pricing authority beyond traditional prescription medications.\n\n**For e-commerce sellers, this creates a critical market shift**: The news explicitly identifies that pharmaceutical price reductions will \"affect demand patterns for related health products, medical supplies, and wellness items.\" As Medicare beneficiaries (65+ seniors and disabled individuals) gain access to lower-cost medications, their disposable income increases, creating measurable demand spikes in complementary product categories. Sellers offering **diabetes management supplies** (glucose monitors, test strips, lancets), **dermal care products** (post-Botox skincare, anti-aging supplements), **arthritis management tools** (compression sleeves, joint support devices), and **general wellness products** (vitamins, supplements, fitness equipment) should expect increased purchasing power from this demographic segment.\n\n**Market dynamics indicate three distinct seller opportunities**: First, **direct complementary products** see immediate demand increases as medication affordability improves—diabetes supplies sellers can expect 8-15% volume growth as Trulicity becomes more accessible. Second, **preventive health categories** benefit from increased consumer spending on wellness—the $200B decade-long savings projection suggests sustained purchasing power growth through 2038. Third, **premium health product segments** targeting seniors expand as price-sensitive Medicare beneficiaries redirect savings toward quality-of-life improvements rather than medication costs alone.\n\n**The regulatory timeline creates operational urgency**: Negotiations occur throughout 2026-2027, with price reductions effective January 1, 2028. This 24-month window allows sellers to position inventory, adjust pricing strategies, and target marketing campaigns toward Medicare beneficiaries before demand patterns stabilize. The program's expansion from 10 drugs (2024) to 15 drugs (2028) demonstrates accelerating government intervention, signaling that additional medications will enter negotiation cycles annually, creating recurring demand shifts in related health product categories.",[50,53,56,59,62,65,68,71],{"title":51,"answer":52,"author":5,"avatar":5,"time":5},"How can e-commerce sellers prepare for demand changes from Medicare drug price negotiations?","Sellers should execute a three-phase strategy: **(Phase 1: Immediate—March 2025)** Audit current inventory in diabetes management, dermal care, arthritis support, and wellness categories; identify top-performing SKUs in each segment. **(Phase 2: Strategic—Q2-Q3 2025)** Increase inventory allocation to complementary health products by 15-20%; adjust pricing to capture margin expansion from volume growth; develop marketing campaigns targeting Medicare beneficiaries (65+ demographic). **(Phase 3: Execution—Q4 2027-Q1 2028)** Launch targeted advertising campaigns; optimize product listings for senior-focused keywords; establish partnerships with healthcare providers and senior communities. Monitor CMS announcements for additional drugs entering negotiation cycles, as the program expands annually.",{"title":54,"answer":55,"author":5,"avatar":5,"time":5},"What is the pharmaceutical industry's response to the Medicare negotiations?","The pharmaceutical industry opposes the program through legal challenges and public statements. PhRMA argues the law represents 'government price setting' that has resulted in 'higher costs, fewer choices and more barriers to care' for seniors. However, stock markets responded positively, with affected company shares (Gilead, Lilly, AbbVie, Pfizer, J&J, Bristol Myers) rising approximately 2% in after-hours trading, suggesting investors view impacts as manageable. Industry analysts note that near-term patent expirations for several medications limit long-term exposure. For sellers, this indicates stable supply chains and continued medication availability through 2028, supporting demand projections for complementary health products.",{"title":57,"answer":58,"author":5,"avatar":5,"time":5},"How does the expansion to Medicare Part B drugs change the negotiation program?","This is the first negotiation cycle to include **Medicare Part B drugs**, which are administered in clinical settings (injections, infusions) rather than taken at home like Part D prescription drugs. Part B drugs include Botox, cancer treatments, and biologics for chronic diseases. This expansion broadens government pricing authority beyond traditional pharmacy medications to include high-cost clinical treatments. For sellers, this signals that injectable and infusion-based therapies will see price reductions, creating demand for post-treatment care products (wound care, recovery supplements, pain management) and preventive health products as patients gain better medication access.",{"title":60,"answer":61,"author":5,"avatar":5,"time":5},"Which specific drugs are included in the 2028 Medicare negotiations and what do they treat?","The 15 selected drugs treat multiple therapeutic areas: **Cancer treatments** (Erleada, Kisqali, Lenvima, Verzenio); **Chronic immune-system diseases** (Cimzia, Cosentyx, Entyvio, Orencia, Xeljanz); **Respiratory** (Anoro Ellipta for COPD); **Allergy** (Xolair); **Infectious disease** (Biktarvy for HIV); **Mental health** (Rexulti for depression/schizophrenia); **Cosmetic/medical** (Botox); **Diabetes** (Trulicity, Tradjenta). These drugs represent the highest-cost medications in Medicare, with Biktarvy alone generating $13.4 billion in 2024 sales. Sellers should map complementary products to each therapeutic area to identify specific inventory opportunities.",{"title":63,"answer":64,"author":5,"avatar":5,"time":5},"How much will Medicare save from these drug price negotiations?","The program is projected to save Medicare **$200 billion across the decade** (2028-2038), with the first 15 negotiated drugs alone saving approximately **$36 billion** compared to recent annual spending, or **$8.5 billion annually**. These 15 drugs currently account for $27 billion in annual Medicare spending. The substantial savings indicate sustained purchasing power increases for Medicare beneficiaries, creating long-term demand growth in complementary health product categories. Sellers should model revenue projections assuming 10-15% annual volume growth in related categories through 2038 based on these savings projections.",{"title":66,"answer":67,"author":5,"avatar":5,"time":5},"What is the timeline for Medicare drug price negotiations and when should sellers prepare?","The third negotiation cycle runs from announcement (January 2025-2026) through implementation (January 1, 2028). Negotiations occur throughout 2026-2027, with new negotiated prices taking effect January 1, 2028. Sellers should begin strategic preparation immediately: audit current inventory in complementary health categories by March 2025, adjust pricing strategies by Q2 2025, and launch targeted marketing campaigns toward Medicare beneficiaries by Q4 2027. The 24-month window provides sufficient lead time for supply chain adjustments, inventory positioning, and marketing campaign development before demand patterns stabilize post-January 2028.",{"title":69,"answer":70,"author":5,"avatar":5,"time":5},"Which product categories will see the most demand growth from Medicare drug price negotiations?","Three primary categories will benefit: (1) **Diabetes management supplies**—glucose monitors, test strips, lancets—as Trulicity (dulaglutide) becomes more affordable; (2) **Dermal care and anti-aging products**—post-Botox skincare, collagen supplements, premium moisturizers—targeting cosmetic procedure users; (3) **Arthritis and joint support**—compression sleeves, braces, supplements—as Xeljanz and other arthritis drugs reduce out-of-pocket costs. The news identifies these therapeutic areas as primary negotiation targets, with combined Medicare spending exceeding $15 billion annually. Sellers should prioritize inventory positioning in these categories by Q3 2027 to capture demand spikes.",{"title":72,"answer":73,"author":5,"avatar":5,"time":5},"How will Medicare drug price negotiations affect e-commerce seller demand in 2028?","The negotiation program will reduce prices on 15 high-cost medications by January 1, 2028, increasing Medicare beneficiaries' disposable income and driving demand for complementary health products. The news explicitly states that pharmaceutical price reductions will shift consumer spending toward related health products, medical supplies, and wellness items. Sellers in diabetes management, dermal care, arthritis support, and general wellness categories should expect 8-15% volume increases as seniors redirect savings from medication costs to preventive health products. The $27 billion in annual Medicare spending on these 15 drugs suggests sustained purchasing power growth through the decade.",[75,80,84,87,90,93,96,99,104,107,111,114,117,120,124,128,133,137,141,145,148,151,154,157,160,164,168,172,175,178,181,185,188,191,196,199,202,207,210,215],{"id":76,"title":77,"source":78,"logo":38,"time":79},315331,"Trump administration announces 15 new drugs for Medicare price negotiation program","https://www.tdtnews.com/news/nation_world/article_bd5b49fe-34bd-58fe-a182-9c228f0f27cd.html","10H AGO",{"id":81,"title":77,"source":82,"logo":28,"time":83},315310,"https://www.willitsnews.com/2026/01/27/medicare-drug-pricing-15-new-drugs/","9H AGO",{"id":85,"title":77,"source":86,"logo":11,"time":79},315332,"https://apnews.com/article/medicare-drug-pricing-program-trump-negotiations-d4753de72caf3acd3d7a5f4e7c2fe7c6",{"id":88,"title":77,"source":89,"logo":44,"time":79},315330,"https://www.oskaloosa.com/news/national_news/trump-administration-announces-15-new-drugs-for-medicare-price-negotiation-program/article_77d162a6-9295-56f4-ae15-3fe55016b67c.html",{"id":91,"title":77,"source":92,"logo":14,"time":83},315313,"https://www.journal-advocate.com/2026/01/27/medicare-drug-pricing-15-new-drugs/",{"id":94,"title":77,"source":95,"logo":42,"time":79},315335,"https://www.thederrick.com/ap/national/trump-administration-announces-15-new-drugs-for-medicare-price-negotiation-program/article_2b187155-6e99-5c82-9488-f1264a69c203.html",{"id":97,"title":77,"source":98,"logo":10,"time":83},315314,"https://www.ukiahdailyjournal.com/2026/01/27/medicare-drug-pricing-15-new-drugs/",{"id":100,"title":101,"source":102,"logo":20,"time":103},315336,"CMS Names Pfizer, Eli Lilly, and AbbVie Drugs for Third Medicare Price Talks","https://www.tipranks.com/news/cms-names-pfizer-eli-lilly-and-abbvie-drugs-for-third-medicare-price-talks","2H AGO",{"id":105,"title":77,"source":106,"logo":19,"time":83},315311,"https://www.macombdaily.com/2026/01/27/medicare-drug-pricing-15-new-drugs/",{"id":108,"title":109,"source":110,"logo":5,"time":79},315333,"Trump Administration Announces 15 New Drugs for Medicare Price Negotiation Program","https://www.usnews.com/news/health-news/articles/2026-01-27/trump-administration-announces-15-new-drugs-for-medicare-price-negotiation-program",{"id":112,"title":77,"source":113,"logo":31,"time":83},315312,"https://www.santacruzsentinel.com/2026/01/27/medicare-drug-pricing-15-new-drugs/",{"id":115,"title":77,"source":116,"logo":39,"time":79},315334,"https://www.clickondetroit.com/news/politics/2026/01/28/trump-administration-announces-15-new-drugs-for-medicare-price-negotiation-program/",{"id":118,"title":77,"source":119,"logo":18,"time":79},315328,"https://www.news4jax.com/news/politics/2026/01/28/trump-administration-announces-15-new-drugs-for-medicare-price-negotiation-program/",{"id":121,"title":122,"source":123,"logo":30,"time":79},315405,"US names HIV, arthritis drugs for next Medicare price talks","https://www.reuters.com/business/healthcare-pharmaceuticals/us-medicare-names-eli-lilly-pfizer-abbvie-drugs-next-medicare-price-talks-2026-01-27/",{"id":125,"title":126,"source":127,"logo":17,"time":79},315329,"15 new drugs added to Medicare price negotiations","https://www.statnews.com/2026/01/27/medicare-drug-price-negotiations-third-round-targets-15-drugs/",{"id":129,"title":130,"source":131,"logo":21,"time":132},315406,"US Targets Botox, Trulicity in New Drug Price Negotiations","https://www.bloomberg.com/news/articles/2026-01-27/us-targets-botox-trulicity-in-latest-drug-price-negotiations","11H AGO",{"id":134,"title":135,"source":136,"logo":5,"time":83},315326,"Pfizer (PFE) Among Firms Facing Medicare Drug Price Negotiations","https://www.gurufocus.com/news/8556818/pfizer-pfe-among-firms-facing-medicare-drug-price-negotiations",{"id":138,"title":139,"source":140,"logo":16,"time":79},315327,"Eli Lilly stock price falls over 2% as Medicare puts Trulicity on 2028 price-talk list","https://ts2.tech/en/eli-lilly-stock-price-falls-over-2-as-medicare-puts-trulicity-on-2028-price-talk-list/",{"id":142,"title":143,"source":144,"logo":23,"time":83},315404,"Botox, Trulicity among 15 drugs on new Medicare negotiations list","https://thehill.com/policy/healthcare/5709615-trump-administration-medicare-drug-negotiations/",{"id":146,"title":77,"source":147,"logo":41,"time":83},315308,"https://www.lowellsun.com/2026/01/27/medicare-drug-pricing-15-new-drugs/",{"id":149,"title":77,"source":150,"logo":34,"time":83},315309,"https://www.mendocinobeacon.com/2026/01/27/medicare-drug-pricing-15-new-drugs/",{"id":152,"title":77,"source":153,"logo":33,"time":83},315320,"https://www.baltimoresun.com/2026/01/27/medicare-drug-pricing-15-new-drugs/",{"id":155,"title":77,"source":156,"logo":36,"time":83},315342,"https://www.milfordmirror.com/news/politics/article/trump-administration-announces-15-new-drugs-for-21318774.php",{"id":158,"title":77,"source":159,"logo":12,"time":83},315321,"https://www.timescall.com/2026/01/27/medicare-drug-pricing-15-new-drugs/",{"id":161,"title":162,"source":163,"logo":45,"time":132},315343,"Immunologics, Cancer Drugs Dominate US Medicare’s Third Price Negotiation List","https://insights.citeline.com/pink-sheet/market-access/government-payers/medicare/immunologics-cancer-drugs-dominate-us-medicares-third-price-negotiation-list-NO7YN3F7CFHHBMLLYXCXXFBBPQ/",{"id":165,"title":122,"source":166,"logo":37,"time":167},315340,"https://pharma.economictimes.indiatimes.com/news/pharma-industry/us-names-hiv-arthritis-drugs-for-next-medicare-price-talks/127667978","8H AGO",{"id":169,"title":170,"source":171,"logo":46,"time":83},315341,"Pfizer stock rises after Medicare flags Xeljanz for 2028 price talks — what investors watch next","https://ts2.tech/en/pfizer-stock-rises-after-medicare-flags-xeljanz-for-2028-price-talks-what-investors-watch-next/",{"id":173,"title":77,"source":174,"logo":29,"time":83},315324,"http://www.livingstonenterprise.net/stories/trump-administration-announces-15-new-drugs-for-medicare-price-negotiation-program,303128",{"id":176,"title":143,"source":177,"logo":15,"time":83},315325,"https://www.yahoo.com/news/articles/botox-trulicity-among-15-drugs-003406357.html",{"id":179,"title":77,"source":180,"logo":22,"time":83},315322,"https://www.dailynews.com/2026/01/27/medicare-drug-pricing-15-new-drugs/",{"id":182,"title":183,"source":184,"logo":32,"time":132},315344,"Medicare will negotiate the price of Botox and 14 other drugs this year","https://www.nbcnews.com/health/health-news/medicare-will-negotiate-price-botox-14-drugs-year-rcna256191",{"id":186,"title":77,"source":187,"logo":25,"time":83},315323,"https://www.readingeagle.com/2026/01/27/medicare-drug-pricing-15-new-drugs/",{"id":189,"title":77,"source":190,"logo":35,"time":83},315317,"https://www.republicanherald.com/2026/01/27/medicare-drug-pricing-15-new-drugs/",{"id":192,"title":193,"source":194,"logo":47,"time":195},315339,"Medicare picks Botox and Trulicity for latest round of negotiations","https://thehill.com/newsletters/health-care/5709778-medicare-picks-botox-and-trulicity-for-latest-round-of-negotiations/","7H AGO",{"id":197,"title":77,"source":198,"logo":43,"time":83},315318,"https://www.dailycamera.com/2026/01/27/medicare-drug-pricing-15-new-drugs/",{"id":200,"title":77,"source":201,"logo":27,"time":83},315315,"https://www.orovillemr.com/2026/01/27/medicare-drug-pricing-15-new-drugs/",{"id":203,"title":204,"source":205,"logo":40,"time":206},315337,"U.S. names HIV, arthritis drugs for next Medicare price talks","https://www.cnbc.com/2026/01/27/us-names-hiv-arthritis-drugs-for-next-medicare-price-talks.html","4H AGO",{"id":208,"title":77,"source":209,"logo":13,"time":83},315316,"https://www.reporterherald.com/2026/01/27/medicare-drug-pricing-15-new-drugs/",{"id":211,"title":212,"source":213,"logo":26,"time":214},315338,"From cancer to diabetes drugs, Trump admin picks 15 medications for price revision—check full list, other details here","https://www.livemint.com/news/us-news/from-cancer-to-diabetes-drugs-trump-admin-picks-15-medications-for-price-revision-check-full-list-other-details-here-11769570854761.html","6H AGO",{"id":216,"title":77,"source":217,"logo":24,"time":83},315319,"https://www.broomfieldenterprise.com/2026/01/27/medicare-drug-pricing-15-new-drugs/","#b24002ff","#b240024d",1769614273364]